BeOne Medicines Ltd. (ONC) earnings
Quarterly results of BeOne Medicines Ltd. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
BeOne Medicines Ltd. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) BeOne Medicines Ltd. reported revenue of $1.7B (+29.6% on the same quarter a year earlier) and net income of $237M (+151.3% on the same quarter a year earlier).
Diluted earnings per share were $0.16 (+166.7% on the same quarter a year earlier).
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $1.7B | +29.6% | $237M | $0.16 |
| Q1 FY2026 | $1.5B | +35.5% | $227.4M | $0.15 |
| Q4 FY2025 | $1.5B | +32.8% | $66.5M | - |
| Q3 FY2025 | $1.4B | +41% | $124.8M | $0.08 |
| Q2 FY2025 | $1.3B | - | $94.3M | $0.06 |
| Q1 FY2025 | $1.1B | - | $1.3M | $0.00 |
| Q4 FY2024 | $1.1B | - | -$151.9M | - |
| Q3 FY2024 | $1B | - | -$121.4M | -$0.09 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
When is BeOne Medicines Ltd.'s next earnings date?
BeOne Medicines Ltd. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
What were BeOne Medicines Ltd.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, BeOne Medicines Ltd. reported revenue of $1.7B and net income of $237M (+151.3% on the same quarter a year earlier). The figures come from its filing with the SEC.
Is BeOne Medicines Ltd.'s revenue growing?
Revenue in Q2 FY2026 was $1.7B, up 29.6% from $1.3B in the same quarter a year earlier.
Get an email when ONC reports
Follow ONC and we email you its next results the day they are filed, with the numbers explained.